These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17979686)

  • 21. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah MK; Vandendriessche T
    Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.
    Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA
    Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
    Jooss K; Turka LA; Wilson JM
    Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
    Yang Y; Haecker SE; Su Q; Wilson JM
    Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses to gene-modified T cells.
    Muul LM; Candotti F
    Curr Gene Ther; 2007 Oct; 7(5):361-8. PubMed ID: 17979682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal and neonatal gene therapy: benefits and pitfalls.
    Waddington SN; Kennea NL; Buckley SM; Gregory LG; Themis M; Coutelle C
    Gene Ther; 2004 Oct; 11 Suppl 1():S92-7. PubMed ID: 15454963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes.
    Jung D; Jaeger E; Cayeux S; Blankenstein T; Hilmes C; Karbach J; Moebius U; Knuth A; Huber C; Seliger B
    Hum Gene Ther; 1998 Jan; 9(1):53-62. PubMed ID: 9458242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Somatic gene therapy. Initial clinical applications and current research approach].
    Runge DM; Runge D
    Fortschr Med; 1995 Aug; 113(24):337-40. PubMed ID: 7590552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX.
    Bigger BW; Siapati EK; Mistry A; Waddington SN; Nivsarkar MS; Jacobs L; Perrett R; Holder MV; Ridler C; Kemball-Cook G; Ali RR; Forbes SJ; Coutelle C; Wright N; Alison M; Thrasher AJ; Bonnet D; Themis M
    Gene Ther; 2006 Jan; 13(2):117-26. PubMed ID: 16163377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer.
    Pützer BM; Bramson JL; Addison CL; Hitt M; Siegel PM; Muller WJ; Graham FL
    Hum Gene Ther; 1998 Mar; 9(5):707-18. PubMed ID: 9551618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen.
    He XS; Chen HS; Chu K; Rivkina M; Robinson WS
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7274-8. PubMed ID: 8692982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal Immune Tolerance Induction to Allow Long-Term Studies With an Immunogenic Therapeutic Monoclonal Antibody in Mice.
    Piccand M; Bessa J; Schick E; Senn C; Bourquin C; Richter WF
    AAPS J; 2016 Mar; 18(2):354-61. PubMed ID: 26603888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors.
    Zepeda M; Wilson JM
    Gene Ther; 1996 Nov; 3(11):973-9. PubMed ID: 8940637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In utero injection of alpha-L-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression.
    Meertens L; Zhao Y; Rosic-Kablar S; Li L; Chan K; Dobson H; Gartley C; Lutzko C; Hopwood J; Kohn D; Kruth S; Hough MR; Dubé ID
    Hum Gene Ther; 2002 Oct; 13(15):1809-20. PubMed ID: 12396614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
    Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
    J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemophilia Gene Therapy: Ready for Prime Time?
    VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses.
    Ilan Y; Sauter B; Chowdhury NR; Reddy BV; Thummala NR; Droguett G; Davidson A; Ott M; Horwitz MS; Chowdhury JR
    Hepatology; 1998 May; 27(5):1368-76. PubMed ID: 9581693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.